SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

PURPOSE: To evaluate the systemic pharmacokinetics (PKs) of aflibercept, bevacizumab, and ranibizumab in patients with neovascular age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion (RVO). METHODS: Prospective, open-label, nonrandomized clinical trial of...

Full description

Saved in:
Bibliographic Details
Published in:Retina
Main Authors: Avery, Robert L., Castellarin, Alessandro A., Steinle, Nathan C., Dhoot, Dilsher S., Pieramici, Dante J., See, Robert, Couvillion, Stephen, Nasir, Ma'an A., Rabena, Melvin D., Maia, Mauricio, Van Everen, Sherri, Le, Kha, Hanley, William D.
Format: Artigo
Language:Inglês
Published: Retina 2017
Subjects:
Original Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642319/
https://ncbi.nlm.nih.gov/pubmed/28106709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000001493
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items